This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Can Express Scripts Maintain Its Momentum?

By David Russell, reporter at OptionMonster

NEW YORK -- Traders apparently expect Express Scripts (ESRX) to keep its momentum into early next year.

OptionMonster's tracking systems detected the purchase of 2,000 January 70 calls for $2.95 and the sale of an equal number of January 60 calls for $8.75. Volume was below open interest in the 60s, which suggests that an existing position was closed and rolled to the higher strike.

These calls lock in the price where shares can be purchased in the provider of pharmacy benefits. Investors use them for cheap upside exposure, leveraging small moves and managing risk in the process.

In Monday's case, traders had apparently made money on a long bet in the January 60s. Adjusting to January 70s let him or her to collect $5.80 while remaining positioned for further gains.

Express Scripts' shares rose 0.86% Monday to close at $67.07, another new all-time high. Earnings have beaten expectations for at least four straight quarters, and the stock has been running since bottoming around $50 in November. The next quarterly report is scheduled for after the close on July 29.

Total option volume was twice the daily average in the session, with calls outnumbering puts by a bullish 4-to-1 ratio.

Russell has no positions in ESRX.
This commentary comes from an independent investor or market observer as part of TheStreet guest contributor program. The views expressed are those of the author and do not necessarily represent the views of TheStreet or its management.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $117.81 -0.19%
FB $105.45 0.04%
GOOG $750.26 0.28%
TSLA $231.61 0.86%
YHOO $32.94 -0.66%


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports